Literature DB >> 26435942

Aerobic Bacteriological Study of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.

Hariom Sharan1.   

Abstract

BACKGROUND: The natural history of chronic obstructive pulmonary disease is characterized by frequent exacerbations. Majority of exacerbations are infectious and bacteria responsible for 30-50% of these cases. The purpose of this study was to determine the bacteriology of acute exacerbations of chronic obstructive pulmonary disease in hospitalized patients in our institution and their antibiotic susceptibility pattern to formulate cost effective antibiotic strategy and reducing the emergence of drug resistance.
MATERIALS AND METHODS: One hundred and seven clinically diagnosed cases of acute exacerbations of chronic obstructive pulmonary disease admitted in medicine, tuberculosis and chest wards were selected for the study. Direct gram stain was done for all sputum samples. The suitable sputum samples were cultured. Identification of organism and antimicrobial susceptibility testing was done by standard microbiological techniques.
RESULTS: Our study showed growth of pathogenic organisms in 41.12% cases. Males (67.29%) are more affected than females (32.71%). Gram negative bacilli were more isolated than gram positive cocci. The commonest isolate was Klebsiella pneumoniae 15 (38.46%), followed by Staphylococcus aureus 9 (23.08%), Streptococcus species 6 (15.39%), Pseudomonas aeruginosa 4 (10.26%), E.coli 2 (5.13%), Acinetobacter species 2 (5.13%) and Enterobacter species 1(2.56%). The antibiotic susceptibility reveals that vancomycin, linezolid, azithromycin and clarithromycin were most effective drugs for gram positive cocci, meropenem & piperacillin-tazobactam for gram negative bacilli and amikacin & levofloxacin for both gram positive cocci & gram negative bacilli.
CONCLUSION: In developing country like India acute exacerbations of chronic obstructive pulmonary disease is common in adults more than 50 years of age due to smoking habits and high indoor pollution. This leads to a major impact on the quality of life of patients with the condition. They are a major cause of hospital admission and health care utilization.

Entities:  

Keywords:  Antibiotic sensitivity pattern; Bacterial aetiology; COPD

Year:  2015        PMID: 26435942      PMCID: PMC4576533          DOI: 10.7860/JCDR/2015/14515.6367

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  4 in total

Review 1.  Acute exacerbations of chronic obstructive pulmonary disease: causes and impacts.

Authors:  Sunil K Chhabra; Devi Jyoti Dash
Journal:  Indian J Chest Dis Allied Sci       Date:  2014 Apr-Jun

2.  Microbial pattern of acute infective exacerbation of chronic obstructive airway disease in a hospital based study.

Authors:  N Arora; M K Daga; R Mahajan; S K Prakash; N Gupta
Journal:  Indian J Chest Dis Allied Sci       Date:  2001 Jul-Sep

Review 3.  Acute exacerbations and respiratory failure in chronic obstructive pulmonary disease.

Authors:  Neil MacIntyre; Yuh Chin Huang
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

4.  Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  M G Seneff; D P Wagner; R P Wagner; J E Zimmerman; W A Knaus
Journal:  JAMA       Date:  1995-12-20       Impact factor: 56.272

  4 in total
  4 in total

1.  Antibiotic de-escalation principle in elderly patients with chronic obstructive pulmonary disease complicated with severe pneumonia.

Authors:  Baohong Xiao; Mei Wang; Xiaoling Hu; Jinfeng Li; Fangfang Wang; Jiaxing Sun
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

2.  Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study.

Authors:  Yinle Lan; Shuxian Li; Dehua Yang; Junfen Zhou; Yingshuo Wang; Jianhua Wang; Yingchun Xu; Zhimin Chen
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

Review 3.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23

Review 4.  Progress in the mechanism and targeted drug therapy for COPD.

Authors:  Cuixue Wang; Jiedong Zhou; Jinquan Wang; Shujing Li; Atsushi Fukunaga; Junji Yodoi; Hai Tian
Journal:  Signal Transduct Target Ther       Date:  2020-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.